Symetry Surgical to expand Japanese distribution; Two U.K. firms developing hand-held gum disease diagnostic;

 @FierceMedDev: Only a few weeks left to submit your nominations for the 15 fiercest private device developers. Survey | Follow @FierceMedDev

> Symetry Surgical, an Indiana-based producer of surgical devices, struck a deal with Japan Surgical Specialty to distribute its devices in Japan. More

> BioBehavorial Diagnostics raised $5.2 million in a private stock sale, the Philadelphia Business Journal reports. The company markets a device designed to measure brain functions in order to help diagnose attention deficit hyperactivity disorder. Story

> VisionCare Ophthalmic Technologies has expanded the provider coverage of its CentraSight device, a telescopic eye implant for patients with end-stage macular degeneration. Release

> ApniCure gained 510(k) clearance to market its Winx sleep therapy system, a device that helps treat obstructive sleep apnea without a mask. Story

> The ECG-producer AliveCor, a division of mHealth, has appointed a new CEO. Judy Wade was previously in charge of a mobile app company, and AliveCor said it will use her expertise to seek 510(k) clearance for an iPhone-compatible ECG device. More

> Health 2.0 and the Office of the National Coordinator for Health Information Technology have awarded $25,000 to a developer who created an online portal for patients and physicians to report adverse events with medical devices. News

@FierceBiotech: Check out this special report from @RyanMFierce: 5 next-gen software tools for biopharma R&D. Report | Follow @FierceBiotech

@RyanMFierce: Hi all, we're about to launch FierceBiotech's Fierce 15 biotech search. Countdown from 10... Survey | Follow @RyanMFierce

> Ohio-based Navidea Biopharmaceuticals has expanded to Andover, MA, north of Boston. Report

> Modulation Therapeutics has garnered a $500,000 award from The Multiple Myeloma Research Foundation as the company works on its lead drug candidate called MTI-101 for myeloma. Release

> Inclinix and PMG Research combine to boost trial enrollment business. Item

> Newton, MA, biotech Chiasma, a developer of oral peptide and protein drugs, has landed $3 million in debt financing. Report

Pharma News

@FiercePharma: India's Aurobindo hopes an FDA inspection this summer will lift import ban on antibiotics plant. More | Follow @FiercePharma

> FDA to again consider making hydrocodone combos class II drugs. More

> Missed forecast by Roche leads to Boniva shortage. News

> Novartis in tax fight over vaccine plant that HHS helped pay for. Story

> GSK extends $2.6 billion bid for Human Genome Sciences. Article

And finally... U.K. companies OJ-Bio and Orla Protein Technologies, working with scientists at Newcastle University, are developing a hand-held diagnostic device designed to rapidly detect early signs of gum disease in saliva, and also monitor the condition as it is treated. Release

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.